Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.

NCT03267173 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
CAR

Interventions

DRUG: Chimeric antigen receptor T cell

Sponsor

First Affiliated Hospital of Harbin Medical University

Collaborators

[object Object]